Millions of women worldwide suffer from cervical cancer, and treating the disease is a never-ending task. Pertuzumab has become a ray of hope for many people in this situation. The HER2 protein, which is overexpressed in several cancers, particularly cervical carcinoma, is the primary target of this monoclonal antibody. Pertuzumab stops the unchecked spread of cancer cells by attachin... https://westaidvisasolutions.com/